---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-001685"
form_type: "8-K"
ticker: "LTRN"
cik: "0001763950"
company_name: "Lantern Pharma Inc."
filed_at: "2025-01-10T23:59:59+00:00"
generated_at: "2026-05-28T05:24:10.511167+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Lantern Pharma amends CSO Bhatia's agreement: term to Jan 2026, reduced hours, $189,600 salary

## Summary
- Kishor G. Bhatia, CSO, employment term extended to January 15, 2026.
- Minimum weekly hours reduced to 24 for scientific, clinical, and therapeutic development.
- Annual base salary proportionately adjusted to $189,600 effective first pay period January 2025.

## SEC filing metadata
- accession: 0001493152-25-001685
- form_type: 8-K
- ticker: LTRN
- cik: 0001763950
- company_name: Lantern Pharma Inc.
- filed_at: 2025-01-10T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1763950/000149315225001685/0001493152-25-001685-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1763950/000149315225001685/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-001685
- JSON: https://secwatch.observer/filing/0001493152-25-001685.json
- Plain text: https://secwatch.observer/filing/0001493152-25-001685.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.